Molteni Therapeutics renews its Quality Management System according to UNI ENI ISO 9001:2015 & UNI CEI EN ISO 13485:2016
Molteni Therapeutics Receives CE Mark for Its New Product ELKOFAST® gel 0.3%
Partecipation to the 5th Congress of WUWHS
Molteni Therapeutics is looking for Business partners for Licensing and post-market development
Molteni Therapeutics Receives CE Mark for Its New Product VULNOFAST® plus
Molteni Therapeutics Receives CE Mark for Its New light source VULNOLIGHT®
Molteni Therapeutics Receives CE Mark for Its New Product VULNOFAST® gel